Concepedia
Statistics
Publications
64
Citations
5.1K
H-Index
38
Active since
1987
Affiliations
Sorbonne Université(Current)
Pitié-Salpêtrière Hospital
Hôpital Saint-Louis
Hôpital Cochin
Hôpital Edouard Herriot
V. Leblond is an author at Sorbonne Université specializing in medicine, hematology, and oncology.
Publications per year
1987–2023
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
Nöel Milpied, B. Vasseur, Nathalie Parquet et al. · Annals of Oncology · 2000 · 376 citations · Full text
Life Sciences, Hematology, Immunology +16
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
V. Leblond, Frédéric Davi, Frédéric Charlotte et al. · Journal of Clinical Oncology · 1998 · 363 citations
Medicine, Hematology, Pathology +10
IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS
D Maraninchi, Didier Blaise, Bernard Rio et al. · The Lancet · 1987 · 307 citations
Medicine, Hematology, Immunology +10
Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
V. Leblond, Laurent Sutton, Richard Dorent et al. · Journal of Clinical Oncology · 1995 · 280 citations
Medicine, Immunology, Pathology +16
Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.
Patricia Yotnda, Hüseyin Firat, Francisco Garcia‐Pons et al. · Journal of Clinical Investigation · 1998 · 239 citations · Full text
Life Sciences, Immunology, Oncology +14
1–5 of 64